Louisville, KY, United States of America

Paul A Spence

This inventor holds 128 USPTO granted patents and 19 published patent applications, plus 8 CIPO patents and 19 EPO patents, primarily in Heart Valve Technology (CPC class A61F2-2418). Top assignees: Mitral Valve Technologies Sarl, Origin Medsystems, Inc., Mitralign, Inc.. Active years: 1999-2026.

USPTO Granted Patents = 128 

% Patents Active = 67.2

 

 

Average Co-Inventor Count = 2.3

ph-index = 50

Forward Citations = 18,467(Granted Patents)

Forward Citations (Not Self Cited) = 17,331(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Irvine, CA (US) (2018)
  • Louisville, KY (US) (1999 - 2024)

Company Filing History:

goldMedal26 out of 26 
 
Mitral Valve Technologies Sarl
 patents
silverMedal18 out of 179 
 
Origin Medsystems, Inc.
 patents
bronzeMedal13 out of 37 
 
Mitralign, Inc.
 patents
4. 11 out of 307 
 
Abiomed, Inc.
 patents
5. 6 out of 11 
 
Cardiovascular Technologies, Inc.
 patents
6. 6 out of 134 
 
Maquet Cardiovascular LLC
 patents
7. 4 out of 238 
 
Heartware, Inc.
 patents
8. 4 out of 4 
 
Ischemicure Ltd.
 patents
9. 2 out of 101 
 
Cardiothoracic Systems, Inc.
 patents
10. 2 out of 16 
 
Guidant Corporation
 patents
11. 2 out of 8 
 
Idx Medical, Ltd.
 patents
12. 2 out of 2 
 
Medtentia
 patents
13. 2 out of 44 
 
Medtentia International Ltd Oy
 patents
14. 2 out of 8,939 
 
Medtronic, Inc.
 patents
15. 2 out of 2 
 
Scr Inc.
 patents
16. 1 out of 1 
 
Cardiac Valve Technologies LLC
 patent
17. 1 out of 1,782 
 
Edwards Lifesciences Corporation
 patents
18. 1 out of 4 
 
Hbx, Inc.
 patents
19. 1 out of 1 
 
Lanark Medical Products
 patent
20. 1 out of 2 
 
Medtentia Ab
 patents
21. 1 out of 1 
 
Mitral Valve Technologies Sari
 patent
22. 20 out of 834,350 
Other
 patents

Years Active: 1999-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Heart Valve
Blood Clots
Mitral Valve
Prosthetic Heart Valve
Counterpulsation
Tissue Anchors
Graft Anchor
Valve Docking
Atrial Wall Cutting
Magnetic Guidance
Flow Facilitation
Replacement Methods
128 patents (USPTO):Explore Patents

Paul A. Spence is a well-known inventor with an impressive collection of patents and a passion for developing new medical devices. Based in Louisville, KY in the US, Mr. Spence has obtained around 100 patents throughout his career, with many of his latest patents focused on providing effective solutions for mitral valve repair and replacement.

One of his recent inventions, an implant and method for repairing or replacing the functionality of the native mitral valve, has the potential to reduce or eliminate mitral regurgitation and residual mitral valve leakage. This implant uses a coiled anchor to position a prosthetic valve in the native mitral valve of a heart. The anchor is designed with three turns, where the second and third turns are positioned in the left ventricle of the heart and around the leaflets of the native mitral valve. The first turn is separated from the native mitral valve, located in the left atrium of the heart. This new approach has the advantage of requiring only one turn of the coiled anchor in the left atrium, making the implantation easier and safer.

Mr. Spence has also been involved in the development of valve docking devices, systems and methods, which could be used to treat conditions such as vein valve insufficiency and deep vein thrombosis. His contributions to these projects were critical, and his coworkers, such as Warren P. Williamson, IV and Mark Steven Ortiz, have hailed him as an innovative and driven inventor with a wealth of knowledge and talent.

Throughout his career, Mr. Spence has been affiliated with companies such as Mitral Valve Technologies Sarl and Abiomed, Inc. His work with these companies has been instrumental in the development of new treatments for cardiovascular diseases, benefiting millions of patients worldwide.

Overall, Paul A. Spence's contributions to the field of medical devices are impressive, and his passion for innovation is apparent. His dedication to improving patient outcomes and developing new treatment options have positioned him as one of the most talented inventors of his generation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…